whatshot

CTOR   $1.02  6.94% Market Closed After Close 1.01 -0.98%

Citius Oncology, Inc.
show_chart Advanced Chart of CTOR

Current temperature: 6.25
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 1
Target Price Mean 4.00
Mean unverified/preliminary 4.00 / 4.00
Target Price Low / High 4.00 / 4.00
Median / STD DEV 4.00 / 0.00
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell None Sell
rsi None Sell Sell
macd None None None
stoch ActivelyBuy None None
ma20 Sell Buy None
ma50 ActivelyBuy None None
ma100 Sell Buy None
Candlestick PatternSept. 15, 2026 Bearish Engulfing - is characterized by a large black body engulfing a preceding smaller white body, which appears during a downtrend. Considered to be a bearish reversal pattern.
ISIN US17331Y1091
ceo Mr. Leonard L. Mazur
Citius Oncology, Inc. focuses on the development of novel targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adults with relapsed or refractory cutaneous T-cell lymphoma. The company is headquartered in New York, New York.Citius Oncology, Inc. operates as a subsidiary of Citius Pharmaceuticals, Inc.